Next Generation Blood Gas Monitors are the devices used for monitoring the level of arterial oxygen tension (pO2), carbon dioxide tension (pCO2), and acidity (pH), these parameters assist in disease diagnosis such as shock, overdose of a particular drug, pulmonary disorder etc. The Next Generation Blood Gas Monitors are vital devices for CCU and ICU rooms in the hospital. 

The global Next Generation Blood Gas Monitors System market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Next Generation Blood Gas Monitors System volume and value at global level, regional level and company level. From a global perspective, this report represents overall Next Generation Blood Gas Monitors System market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Next Generation Blood Gas Monitors System in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Next Generation Blood Gas Monitors System manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Medica
Bayer
Radiometer Medical
Convergent
Abbott Point of Care
Alere
Nova Biomedical
Roche
Siemens
Samsung 
Erba
Nova Stat
Edan Instruments
Alere
Dalko Diagnostics

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Bench Top
Portable

Segment by Application
Hospitals
Cardiac Centers
Clinical Laboratories
Others